
CAS 1809249-37-3: Remdesivir
Formula:C27H35N6O8P
InChI:InChI=1S/C27H35N6O8P/c1-4-18(5-2)13-38-26(36)17(3)32-42(37,41-19-9-7-6-8-10-19)39-14-21-23(34)24(35)27(15-28,40-21)22-12-11-20-25(29)30-16-31-33(20)22/h6-12,16-18,21,23-24,34-35H,4-5,13-14H2,1-3H3,(H,32,37)(H2,29,30,31)/t17-,21+,23+,24+,27-,42-/m0/s1
InChI key:InChIKey=RWWYLEGWBNMMLJ-YSOARWBDSA-N
SMILES:C(#N)[C@]1(O[C@H](COP(OC2=CC=CC=C2)(N[C@H](C(OCC(CC)CC)=O)C)=O)[C@@H](O)[C@H]1O)C=3N4C(=CC3)C(N)=NC=N4
Synonyms:- GS 5734
- Remdesiver
- 2-Ethylbutyl N-[(S)-[2-C-(4-aminopyrrolo(2,1-f)(1,2,4)triazin-7-yl)-2,5-anhydro-D-altrononitril-6-O-yl]phenoxyphosphoryl]-L-alaninate
- 2-Ethylbutyl (2S)-2-[[[[(2R,3S,4R,5R)-5-(4-aminopyrrolo(2,1-f)(1,2,4)triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl]methoxy]phenoxyphosphoryl]amino]propanoate
- L-Alanine, N-[(S)-hydroxyphenoxyphosphinyl]-, 2-ethylbutyl ester, 6-ester with 2-C-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-2,5-anhydro-D-altrononitrile
- Remdesivir
Sort by
Found 20 products.
Remdesivir Carboxylic Acid
CAS:Controlled ProductFormula:C21H23N6O8PColor and Shape:NeatMolecular weight:520.43Remdesivir
CAS:Remdesivir (GS-5734) is a nucleoside analog, a broad-spectrum antiviral compound that exerts its activity by inhibiting the RNA-dependent RNA polymerase ofFormula:C27H35N6O8PPurity:100% - 99.98%Color and Shape:SolidMolecular weight:602.58Ref: TM-T7766
1mg119.00€5mg323.00€10mg510.00€25mg757.00€50mg938.00€100mg1,434.00€200mg1,882.00€1mL*10mM (DMSO)427.00€Remdesivir
CAS:Formula:C27H35N6O8PPurity:≥ 98.0%Color and Shape:White to off-white crystalline powderMolecular weight:602.56Desalanyl Remdesivir
CAS:Controlled ProductFormula:C18H18N5O7PColor and Shape:NeatMolecular weight:449.35Desamino Remdesivir Triazinone
CAS:Controlled ProductFormula:C27H34N5O9PColor and Shape:NeatMolecular weight:603.561Remdesivir
CAS:GS 5734, also known as remdesivir is a nucleoside prodrug with broad spectrum antiviral activity against RNA viruses. As remdesivir / GS 5734 is a prodrug, it requires to be triphosphorylated by cellular kinases in order to compete with ATP for incorporation in newly replicated viral RNA. A major benefit of remdesivir in comparison with other antiviral nucleoside analogs is its resistance to proofreading exonucleases, which occur in coronaviruses. This means remdesivir can overcome the repair mechanism and preserve its antiviral activity. Remdesivir was reported to have a therapeutic as well as prophylactic efficacy in a mouse model infected with SARS-CoV-1.Formula:C27H35N6O8PPurity:Min. 98 Area-%Color and Shape:PowderMolecular weight:602.58 g/molRemdesivir
CAS:RemdesivirFormula:C27H35N6O8P·CH3SO3HPurity:By hplc: 99.89% (Typical Value in Batch COA)Color and Shape: white solidMolecular weight:698.68g/molRemdesivir 5’-Desphosphate 2’-O-[(S)phosphate]
CAS:Controlled ProductFormula:C27H35N6O8PColor and Shape:NeatMolecular weight:605.60Remdesivir-d4
CAS:Formula:C27H31D4N6O8PColor and Shape:White To Off-White SolidMolecular weight:606.61Remdesivir Related Compound 6-13C,D3,15N2
CAS:Controlled ProductFormula:CC11D3H1015N2N3O4Color and Shape:NeatMolecular weight:297.261Bi(alanine 2-Ethylbutyl Ester)Phenyl Phosphenite
CAS:Controlled ProductFormula:C24H41N2O6PColor and Shape:NeatMolecular weight:484.57Remdesivir 5’-Desphosphate 3’-O-[(S)phosphate]
CAS:Controlled ProductFormula:C27H35N6O8PColor and Shape:NeatMolecular weight:605.60